See All Slides - tctmd.com

Slides

Presentation THT 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Effect of the Reprieve Decongestion System Based on Serum Chloride Levels: A Sub Analysis of the FASTR Randomized Controlled Trial

Presenter: Sean Collins

February 11, 2025

Presentation THT 2025

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Presenter: Kamran Muhammad

February 11, 2025

Presentation THT 2025

Discuss Escalation Strategies for Patients in HF-CS

Presenter: Jane Wilcox

February 11, 2025

Presentation THT 2025

Shaping the Future of Heart Failure

Presenter: Anu Lala-Trindade (Lala)

February 11, 2025

Presentation THT 2025

All NYHA III Patients Should Have a PA Pressure Sensor

Presenter: Michael Givertz

February 11, 2025

Presentation THT 2025

Anti-Amyloid Therapy – Will Depleters Change the Game?

Presenter: Scott Solomon

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

Advertisement

Slides

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Effect of the Reprieve Decongestion System Based on Serum Chloride Levels: A Sub Analysis of the FASTR Randomized Controlled Trial

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Discuss Escalation Strategies for Patients in HF-CS

Shaping the Future of Heart Failure

All NYHA III Patients Should Have a PA Pressure Sensor

Anti-Amyloid Therapy – Will Depleters Change the Game?

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content